Redefining clinical trials: Adopting AI for speed, volume and diversity
IBM Services
MAY 6, 2024
Our analysis of the voluntarily reported Form FDA 1572 BMIS database reveals a potential lack of sustainability in the investigator pool, both in the United States (US) and globally (Exhibit 2). The number of first-time clinical investigators has declined, especially among non-US based investigators.
57 
Let's personalize your content